Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Microdosing GLP-1/GIP therapies may help: Improve glycemic control, stable blood glucose levels, and blood pressure support Reduction in visceral fat and waist circumference Potential improvements in lipid profiles Reduce systemic inflammation markers associated with cardiometabolic disease Glycine amino acid that supports protein synthesis, endothelial function, and insulin sensitivity Reduce cardiovascular risk factors such as insulin resistance and central adiposity Whats Included Monthly compounded tirzepatide + glycine (Up to 3mg/week) or 2ml tirzepatide with B12 every 2 months with labs Personalized microdosing protocol Ongoing provider oversight with labs every six months This is not an FDA-approved microdosing regimen
Long-term use of GLP-1 drugs can make them less effective, requiring dosage changes or different medications
Traditional 503A pharmacies (state-licensed compounders) are restricted to patient-specific prescriptions and cannot produce large batches for distribution
Mantngase en su envase original protegido de la luz y el calor, a una temperatura inferior a 30C y 65% de humedad relativa
Novo Nordisk was permitted to bombard the American public with TV ads for Wegovy for nine months before the medications supply shortage was deemed resolved by the FDA
US$ 25.77
US$ 26.75
US$ 28.89
US$ 21.11
US$ 26.06
